Neonata l Hyperbilirubinemia. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: Newborns in the control group underwent routine daily care and transcutaneous bilirubin level measured (from the first day to the fifth day postnatal) daily . Intervention 2: Treatmen
Prevention
Newborns in the control group underwent routine daily care and transcutaneous bilirubin level measured (from the first day to the fifth day postnatal) daily .
Treatment group, were given 5 mg of zinc sulfate daily till day fifth of age . transcutaneous bilirubin level measured from the first day to the fifth day postnatally
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: The main inclusion criteria included:healthy term newborn with birth weight>2500, breast feeding and postnatal age less than 24 h. and exclusion criteria were : congenital anomaly, cephalhematoma?blood group incompatibility ,infection, formula feeding, exchange transfusion in previous sibling .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transcutaneus Bilirubin. Timepoint: Each 24h. Method of measurement: By Bilimeter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Stool frequency. Timepoint: Each 24 h. Method of measurement: Inspection by Mother. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHoma Babaei, MD
Kermanshah University of Medical Sciences
Outcome results
None listed